Management and diagnosis of dry eye

Article

The TearLab Osmolarity System is the Gold Standard for diagnosing and managing Dry Eye Disease with a quantitative, objective endpoint.

Dry Eye - Management and diagnosis

The TearLab Osmolarity System is the first objective and quantitative test for diagnosing and managing Dry Eye patients.

  • Provides fast and accurate results in seconds using only 50 nanolitres (nL) of tear film to diagnose Dry Eye Disease
  • Enables discussion with patients around a number, improving compliance
  • Incorporating osmolarity into the standard of care gives the best indication of early stage disease

The TearLab Osmolarity System is intended to measure the osmolarity of tears to aid in the diagnosis of dry eye disease, in conjunction with other methods of clinical evaluation. TearLab is for professional in vitro diagnostic use only.

Hyperosmolarity has been described in the literature as a primary marker of tear film integrity. When the quantity or quality of secreted tears is compromised (known as aqueous deficient or evaporative Dry Eye Disease), increased rates of evaporation lead to a more concentrated tear film (increased osmolarity) that places stress on the corneal epithelium and conjunctiva.

Company name: TearLab Corp
Address: 9980 Huennekens St. Ste. 100 San Diego, California 92121, USA
Telephone: +1 866-877-TEAR
E-mail: sales@tearlab.comWebsite: www.tearlab.com

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.